What is the medical treatment of the contralateral eye with primary glaucoma?

Master the Lens, Glaucoma, and Fundus Test with focused quizzes and interactive questions. Test your knowledge with insightful explanations and get ready for exam day!

Multiple Choice

What is the medical treatment of the contralateral eye with primary glaucoma?

Explanation:
The essential idea is to actively treat the contralateral eye with primary glaucoma and keep close follow-up to judge response and prevent progression. Dorzolamide 2% given every 12 hours lowers aqueous humor production, reducing IOP in the affected eye and helping both eyes stay controlled when one is dealing with glaucoma. Planning to examine the eye and measure IOP every three months provides a practical, ongoing check on effectiveness and early detection of any worsening, which is crucial in glaucoma management. The addition of retinal support reflects attention to the overall health of the optic nerve and retina as disease risk persists. Other options fall short because they either rely on less frequent monitoring (which risks missing progression), or use regimens that aren’t aligned with the typical surveillance needs in glaucoma, or include inappropriate components (steroids can raise IOP, and pilocarpine with systemic steroids is not a standard or safe combination for this scenario).

The essential idea is to actively treat the contralateral eye with primary glaucoma and keep close follow-up to judge response and prevent progression. Dorzolamide 2% given every 12 hours lowers aqueous humor production, reducing IOP in the affected eye and helping both eyes stay controlled when one is dealing with glaucoma. Planning to examine the eye and measure IOP every three months provides a practical, ongoing check on effectiveness and early detection of any worsening, which is crucial in glaucoma management. The addition of retinal support reflects attention to the overall health of the optic nerve and retina as disease risk persists.

Other options fall short because they either rely on less frequent monitoring (which risks missing progression), or use regimens that aren’t aligned with the typical surveillance needs in glaucoma, or include inappropriate components (steroids can raise IOP, and pilocarpine with systemic steroids is not a standard or safe combination for this scenario).

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy